Contact this trialFirst, we need to learn more about you.
CETP Inhibitor
Obicetrapib for Cholesterol Levels
Recruiting0 awardsPhase 1
Philadelphia, Pennsylvania
This trial aims to study the effect of obicetrapib (a medication) on the rate at which a protein called apolipoprotein B100 is broken down in low-density lipoprotein
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service